BRIEF — Alaunos Therapeutics Buys Velaris Therapeutics On October 13

Oct 13 (Reuters) — Alaunos Therapeutics Inc: Alaunos Therapeutics - Buys Velaris Therapeutics On October 13, 2026 - Sec Filing Alaunos Therapeutics: Prices $350 Million Pipe Offering Of 687,789 Common Shares At $1.44 And 243,063 Series C Preferred At $1,435.70 - Sec Filing (Reuters.Briefs@thomsonreuters.com;)